🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,315 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8426611

7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses

THERON PHARMACEUTICALS, INC. · Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8426597

Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases

CARDIOLYNX AG · Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8420669

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic recept

Laboratories Almirall, S.A. · Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8420694

Pyrrolidin-2-one derivatives as androgen receptor modulator

Takeda Pharmaceutical Company Limited · Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8410292

Epoxy-guaiane derivatives and treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8410272

Pyrazolylbenzothiazole derivatives and their use as therapeutic agents

Dermira (Canada), Inc. · Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8404643

Metastin derivatives and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8404222

Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound mo

Nektar Therapeutics · Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8399493

Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors

Addex Pharmaceuticals S.A. · Granted Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8399449

Fused heterocyclic derivative and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8388963

Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8389557

Triazole derivatives useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8383628

Pyridyl derivatives and their use as therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8383785

Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides

Enanta Pharmaceuticals, Inc. · Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8383647

Quinoline derivative

Takeda Pharmaceutical Company Limited · Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8372860

Carboline derivatives useful in the inhibition of angiogenesis

PTC THERAPEUTICS, INC. · Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8367694

Carboline derivatives useful in the inhibition of angiogenesis

PTC THERAPEUTICS, INC. · Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8367655

Pyridoindolobenzox—and thiazepine derivatives and uses thereof

DAYA DRUG DISCOVERIES, INC. · Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8367690

Aminopyridine derivatives having aurora a selective inhibitory action

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8361968

Metastin derivatives and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8362032

Bicyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8357702

Bicyclic derivatives as modulators of voltage gated ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8354477

Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol

Nektar Therapeutics · Granted Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8350065

5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same

GRANDPHARMA (CHINA) CO., LTD. · Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted